barr 832 2 1/2
Pill imprint barr 832 2 1/2 has been identified as Warfarin sodium 2.5 mg.
Warfarin is used in the treatment of heart failure; prevention of thromboembolism in atrial fibrillation; heart attack; deep vein thrombosis, first event; thromboembolic stroke prophylaxis (and more), and belongs to the drug class coumarins and indandiones. Not for use in pregnancy.
Warfarin 2.5 mg is not subject to the Controlled Substances Act.
See also related documents.
Warfarin sodium Images
- Imprint:
-
barr
832 2 1/2 - Strength:
- 2.5 mg
- Color:
- Green
- Size:
- 11.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- lactose anhydrous
hypromellose
magnesium stearate
corn starch
D&C Yellow No. 10
FD&C Blue No. 1
- Drug Class:
- Coumarins and indandiones
- Pregnancy Category:
- X - Not for use in pregnancy
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Barr Laboratories, Inc.
- National Drug Code (NDC):
- 00555-0832
| NDC Code | Manufacturer / Repackager |
|---|---|
| 66336-0251 | Dispensing Solutions Inc. (repackager) |
| 54868-4400 | Physicians Total Care Inc (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Warfarin Sodium resources
- Warfarin
- Warfarin (Wolters Kluwer)
- Warfarin Tablets (Wolters Kluwer)
- warfarin (Cerner Multum)
- warfarin (Micromedex) - Includes Dosage Information
- warfarin Intravenous (Micromedex) - Includes Dosage Information
- Warfarin Sodium (AHFS DI)
- Coumadin Injection (FDA)
- Warfarin (FDA)
- Warfarin Sodium (Wolters Kluwer)
Warfarin Sodium is associated with the treatment of:
- Antiphospholipid Syndrome
- Chronic Central Venous Catheterization
- Deep Vein Thrombosis Prophylaxis after Hip Replacement Surgery
- Deep Vein Thrombosis Prophylaxis after Knee Replacement Surgery
- Deep Vein Thrombosis, First Event
- Deep Vein Thrombosis, Recurrent Event
- Heart Attack
- Heart Failure
- Prevention of Thromboembolism in Atrial Fibrillation
- Prosthetic Heart Valves
- Prosthetic Heart Valves, Mechanical Valves
- Prosthetic Heart Valves, Tissue Valves
- Protein S Deficiency
- Pulmonary Embolism, First Event
- Pulmonary Embolism, Recurrent Event
- Thromboembolic Stroke Prophylaxis
Search Again
